High-dose density neoadjuvant chemotherapy in bulky IB cervical cancer

Gynecologic Oncology

Volumn 128, Issue 1, 2013, Pages 49-53

  Robova, Helena ^a   Rob, Lukas ^a   Halaska, Michael J ^a   Pluta, Marek ^a   Skapa, Petr ^a   Strnad, Pavel ^a   Lisy, Jiri ^a   Komar, Matej ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cervical cancer; High dose density neoadjuvant chemotherapy; Quality of life; Tumor volumometry

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE;

ADULT; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84871926254     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.10.002     Document Type: Article

References (30)

1. G. Delgado, B.N. Bundy, W.C. Fowler, F.B. Stehman, B. Sevin, and W.T. Cresman A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 35 1989 314 320
2. L. Rob, M. Halaska, and H. Robova Nerve-sparing and individually tailored surgery for cervical cancer Lancet Oncol 11 3 2010 292 301
3. P.J. Eifel, M. Morris, J.T. Wharton, and M.J. Oswald The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 29 1994 9 16
4. M.S. Piver, and W.S. Chung Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma Obstet Gynecol 46 1975 507 510
5. M.A. Rettenmaier, D.M. Casanova, J.P. Micha, M.F. Moran, N.S. Ramsanghani, and N.A. Syed Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage IB cervical cancer Cancer 63 1989 220 223
6. M. Frumowitz, C.C. Sun, L.R. Schover, M.F. Munsell, A. Jhingran, and J.T. Wharton Quality of life and sexual functioning in cervical cancer survivors J Clin Oncol 23 30 2005 7428 7436
7. J.P. Micha, B.H. Goldstein, M.A. Rettenmaier, J.V. Brown III, C.R. John, and M. Markman Surgery alone or surgery with combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma Int J Gynecol Cancer 16 2006 1147 1151
8. A. Yeassaian, A. Magistris, R.A. Burger, and B.J. Monk Radical hysterectomy followed by tailored postoperative therapy in the treatments of stage IB2 cervical cancer: feasibility and indication for adjuvant therapy Gynecol Oncol 94 1 2004 61 66
9. A. Sedlis, B.N. Bundy, M.Z. Rotman, S.S. Lentz, L.I. Muderspach, and R.J. Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study Gynecol Oncol 73 2 1999 177 183
10. D. Querleu Morrow CP. Classification of radical hysterectomy Lancet Oncol 9 2008 297 303
11. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, and P. Perego Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 1997 535 540
12. M.Z. Rotman, A. Sedlis, M.R. Piedmonte, B. Bundy, S.S. Lentz, and L.I. Muderspach A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow up of a gynecologic oncology group study Int J Radiat Oncol Biol Phys 65 2006 169 176
13. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs 3rd Cisplatin, radiation and adjutant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
14. F.B. Stehman, S. Ali, H.M. Keys, L.I. Muderspach, W.E. Chafe, and D.G. Gallup Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of Gynecologic Oncology Group trial Am J Obstet Gynecol 197 2007 503.e1 503.e6
15. U. Güth, Olaitan A. Ella WA, R.J. Hadwin, R. Arora, and M. McCormack Total vaginal necrosis. A representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer Int J Gynecol Cancer 20 2010 54 60
16. A.B. de Gonzalez, R.E. Curtis, S.F. Kry, E. Gilbert, S. Lamart, and C.D. Berg Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in US SEER cancer registries Lancet Oncol 12 2011 353 360
17. J.H. Maduro, E. Pras, P.H.B. Willemse, and E.G.E. de Vries Acute and long term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer Cancer Treat Rev 29 2003 471 488
18. M.L. Friedlander, K. Atkinson, J.V. Coppleson, P. Elliot, D. Green, and R. Houghton The integration of chemotherapy into management of locally advanced cervical cancer: a pilot study Gynecol Oncol 19 1984 1 7
19. P. Benedetti Panici, G. Scambia, S. Greggi, P. Di Roberto, G. Baiocchi, and S. Mancuso Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: pilot study Obstet Gynecol 74 1988 344 348
20. J.E. Sardi, A. Giaroli, C. Sananes, M. Ferreira, A. Soderini, and A. Bermudez Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results Gynecol Oncol 67 1997 61 69
21. G.L. Eddy, B.N. Bundy, W.T. Creasman, N.M. Spirtos, R.S. Mannel, and E. Hannigan Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of gynecologic oncology group Gynecol Oncol 106 2007 362 369
22. P. Benedetti-Panici, S. Greggi, A. Colombo, M. Amoroso, D. Smaniotto, and D. Giannarelli Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study J Clin Oncol 20 1 2002 179 188
23. B.U. Sevin, M. Nadji, B. Lampe, Y. Lu, S. Hilsenbeck, and O.R. Koechli Prognostic factors of early stage cervical cancer treated by radical hysterectomy Cancer 76 1995 1978 1986
24. Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials Eur J Cancer 39 2003 2470 2486
25. G. Mountzios, M.A. Dimopoulos, A. Bamias, G. Vourli, H. Kalofonos, and G. Aravantinos Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study Ann Oncol 20 8 2009 1362 1368
26. A.A. Lissoni, N. Colombo, A. Pellegrino, G. Parma, P. Zola, and D. Katsaros A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study Ann Oncol 20 4 2009 660 665
27. J.V. Kumar, D.C. Doval, R. Rao, and S. Rawal A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery Int J Gynecol Cancer 19 3 2009 417 422
28. A. Maneo, S. Chiari, C. Bonazzi, and C. Mangioni Neoadjuvant chemotherapy and conservative surgery for stage 1B1 cervical cancer Gynecol Oncol 111 2008 438 443
29. A.A. Lissoni, N. Colombo, A. Pellegrino, G. Parma, P. Zola, and D. Katsaros A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervicla carcinoma: the Snap-02 Italian Collaborative Study Ann Oncol 20 2009 660 665
30. L. Rob, P. Skapa, and H. Robova Fertility-sparing surgery in patients with cervical cancer Lancet Oncol 12 2 2011 192 200